Search

IJMSC: Investigating the Impact of Polypharmacy and Anticholinergic Medication Burden on Objective Performance in Adults With Multiple Sclerosis

Release Date: March 1, 2024 Valid for Credit through: March 1, 2025 Activity Available Online: To access the article and evaluation online, go to https://www.highmarksce.com/mscare. Target Audience: The target audience for this activity is physicians, advanced practice clinicians, nursing professionals, pharmacists, researchers, and other health care providers involved in the study and management of patients …

Neuromyelitis Optica Spectrum Disorder: Updates on Diagnosis and Treatment Management

Valid: July 7, 2023 through July 6, 2024 Provider Statement This continuing education activity is provided by  Support Statement This activity is supported by an educational grant from Horizon Therapeutics USA, Inc. Activity Description Neuromyelitis optica spectrum disorder (NMOSD) is a rare, relapsing, autoimmune disease of the central nervous system that is characterized by inflammation …